Bright Minds Biosciences
DRUG • NASDAQ • Stock Fundamentals
Bright Minds Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ian McDonald, with a market cap of $846.6M.
Market Cap$846.6M
CEOIan McDonald
CountryCanada
Healthcare
Biotechnology
Most Recent EarningsMay 20, 2026 · 8 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Bright Minds Biosciences FAQ
Common questions about Bright Minds Biosciences
Bright Minds Biosciences (DRUG) has a market capitalization of $846.6M and trades on NASDAQ.